ゼリア新薬工業の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2012/03/23 | 1,428 | 1,436 | 1,428 | 1,430 | +2 | +0.1% | 14,000 |
2012/03/22 | 1,409 | 1,429 | 1,409 | 1,428 | +18 | +1.3% | 11,000 |
2012/03/21 | 1,424 | 1,450 | 1,410 | 1,410 | -13 | -0.9% | 22,000 |
2012/03/19 | 1,410 | 1,430 | 1,410 | 1,423 | +24 | +1.7% | 19,000 |
2012/03/16 | 1,397 | 1,399 | 1,384 | 1,399 | +1 | +0.1% | 8,000 |
2012/03/15 | 1,399 | 1,407 | 1,377 | 1,398 | +24 | +1.7% | 21,000 |
2012/03/14 | 1,413 | 1,413 | 1,374 | 1,374 | -23 | -1.6% | 17,000 |
2012/03/13 | 1,397 | 1,409 | 1,395 | 1,397 | +5 | +0.4% | 11,000 |
2012/03/12 | 1,392 | 1,405 | 1,392 | 1,392 | ±0 | ±0% | 28,000 |
2012/03/09 | 1,367 | 1,393 | 1,367 | 1,392 | +54 | +4% | 66,000 |
2012/03/08 | 1,349 | 1,349 | 1,338 | 1,338 | -4 | -0.3% | 7,000 |
2012/03/07 | 1,342 | 1,343 | 1,322 | 1,342 | -12 | -0.9% | 25,000 |
2012/03/06 | 1,358 | 1,370 | 1,350 | 1,354 | +1 | +0.1% | 21,000 |
2012/03/05 | 1,340 | 1,354 | 1,340 | 1,353 | +19 | +1.4% | 5,000 |
2012/03/02 | 1,353 | 1,353 | 1,334 | 1,334 | -9 | -0.7% | 12,000 |
2012/03/01 | 1,369 | 1,369 | 1,337 | 1,343 | -17 | -1.3% | 10,000 |
2012/02/29 | 1,354 | 1,368 | 1,352 | 1,360 | -6 | -0.4% | 17,000 |
2012/02/28 | 1,356 | 1,370 | 1,356 | 1,366 | +8 | +0.6% | 35,000 |
2012/02/27 | 1,348 | 1,358 | 1,346 | 1,358 | +23 | +1.7% | 15,000 |
2012/02/24 | 1,352 | 1,357 | 1,334 | 1,335 | -15 | -1.1% | 20,000 |
2012/02/23 | 1,336 | 1,350 | 1,336 | 1,350 | +15 | +1.1% | 10,000 |
2012/02/22 | 1,344 | 1,348 | 1,335 | 1,335 | +4 | +0.3% | 19,000 |
2012/02/21 | 1,347 | 1,347 | 1,329 | 1,331 | -17 | -1.3% | 5,000 |
2012/02/20 | 1,348 | 1,348 | 1,345 | 1,348 | ±0 | ±0% | 11,000 |
2012/02/17 | 1,333 | 1,352 | 1,333 | 1,348 | +16 | +1.2% | 20,000 |
2012/02/16 | 1,346 | 1,347 | 1,332 | 1,332 | -24 | -1.8% | 7,000 |
2012/02/15 | 1,349 | 1,356 | 1,349 | 1,356 | +7 | +0.5% | 17,000 |
2012/02/14 | 1,343 | 1,349 | 1,343 | 1,349 | +6 | +0.4% | 13,000 |
2012/02/13 | 1,326 | 1,343 | 1,326 | 1,343 | +18 | +1.4% | 8,000 |
2012/02/10 | 1,332 | 1,332 | 1,325 | 1,325 | -9 | -0.7% | 6,000 |
2012/02/09 | 1,318 | 1,336 | 1,318 | 1,334 | -9 | -0.7% | 13,000 |
2012/02/08 | 1,345 | 1,350 | 1,338 | 1,343 | +8 | +0.6% | 31,000 |
2012/02/07 | 1,341 | 1,343 | 1,335 | 1,335 | -8 | -0.6% | 10,000 |
2012/02/06 | 1,336 | 1,343 | 1,336 | 1,343 | +20 | +1.5% | 6,000 |
2012/02/03 | 1,343 | 1,343 | 1,322 | 1,323 | -21 | -1.6% | 6,000 |
2012/02/02 | 1,330 | 1,350 | 1,316 | 1,344 | +27 | +2.1% | 17,000 |
2012/02/01 | 1,325 | 1,326 | 1,310 | 1,317 | -8 | -0.6% | 5,000 |
2012/01/31 | 1,312 | 1,338 | 1,311 | 1,325 | +14 | +1.1% | 11,000 |
2012/01/30 | 1,315 | 1,315 | 1,311 | 1,311 | -4 | -0.3% | 6,000 |
2012/01/27 | 1,350 | 1,350 | 1,315 | 1,315 | -31 | -2.3% | 22,000 |
2012/01/26 | 1,319 | 1,348 | 1,312 | 1,346 | +27 | +2% | 20,000 |
2012/01/25 | 1,287 | 1,319 | 1,287 | 1,319 | +34 | +2.6% | 11,000 |
2012/01/24 | 1,298 | 1,300 | 1,285 | 1,285 | -25 | -1.9% | 6,000 |
2012/01/23 | 1,298 | 1,318 | 1,298 | 1,310 | -4 | -0.3% | 8,000 |
2012/01/20 | 1,309 | 1,314 | 1,303 | 1,314 | -3 | -0.2% | 16,000 |
2012/01/19 | 1,313 | 1,340 | 1,306 | 1,317 | -21 | -1.6% | 16,000 |
2012/01/18 | 1,305 | 1,338 | 1,305 | 1,338 | +11 | +0.8% | 17,000 |
2012/01/17 | 1,327 | 1,331 | 1,327 | 1,327 | -1 | -0.1% | 10,000 |
2012/01/16 | 1,337 | 1,337 | 1,328 | 1,328 | -29 | -2.1% | 8,000 |
2012/01/13 | 1,358 | 1,359 | 1,349 | 1,357 | +6 | +0.4% | 7,000 |
3101~
3150
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「ゼリア新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ゼリア新薬 | 224,400円 | +13.6% | +29.2% | 2.05% | 11.64倍 | 1.12倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
鳥居薬 | 476,000円 | +12.0% | +28.1% | 2.52% | 26.24倍 | 1.11倍 |
|
JT傘下。柱の抗HIV薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
持田薬 | 331,500円 | +3.0% | +27.5% | 2.41% | 20.99倍 | 0.91倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
ネクセラファーマ | 113,200円 | +197.7% | - | 0.00% | 46.26倍 | 1.48倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
杏林製薬 | 149,900円 | +3.2% | +4.5% | 3.47% | 17.22倍 | 0.66倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
市場注目の銘柄
チャート関連のコラム